House Health Subcommittee Chair Anna G. Eshoo (D-CA) and Rep. Don Young (R-AK) introduced H.R. 6474, the Healthcare Broadband Expansion During COVID-19 Act, which would provide $2 billion to expand telehealth and high-quality internet connectivity at public and nonprofit healthcare facilities, including mobile clinics and temporary health facilities deployed to respond to the coronavirus pandemic.
Last month, FDA approved the RAS inhibitor, daraxonrasib, sponsored by Revolution Medicines Inc. and also known as Rasonque, for patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.
